Drugmakers Stave Off Cheaper Imports With Senate Vote (Update1)
Dec. 15 (Bloomberg) — Drugmakers such as Eli Lilly & Co. staved off a possible influx of cheaper medicines from Canada and other nations after the U.S. Senate voted against loosening importation rules as part of larger health-care legislation. The Senate rejected the amendment by a 51-48 vote, with 60 needed for approval, turning back [...]
